Investor Resources

Heron Therapeutics Q3 2024 Conference Call
11/12/2024 at 8:00 am EST
At Heron, we are unwavering in our commitment to improve the lives of patients. We aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies that bring together our innovative science and technologies with well-known pharmacology to deliver medicines that matter.

Minimum 15 minutes delayed. Source:

Sign-Up for Email Updates

Receive news and updates on Heron’s latest innovations.